Bio-Rad Laboratories, Inc. (BIO)

NYSE: BIO · Real-Time Price · USD

244.25

-2.15 (-0.87%)

At close: Jul 21, 2025, 4:00 PM

231.00

-13.25 (-5.42%)

Pre-market: Jul 22, 2025, 8:16 AM EDT

Bio-Rad Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	2,541	2,567	2,671	2,802	2,923	2,546	Upgrade
Revenue Growth (YoY)	-2.46%	-3.92%	-4.67%	-4.12%	14.81%	10.12%	Upgrade
Cost of Revenue	1,178	1,188	1,244	1,235	1,259	1,108	Upgrade
Gross Profit	1,363	1,379	1,427	1,567	1,663	1,438	Upgrade
Selling, General & Admin	797	814	841.7	827.8	851.02	798.8	Upgrade
Research & Development	291.9	295.9	247.4	256.9	247.34	217.76	Upgrade
Operating Expenses	1,089	1,110	1,089	1,085	1,098	1,017	Upgrade
Operating Income	274.2	269	337.8	482.6	564.74	421.33	Upgrade
Interest Expense	-48.6	-48.9	-49.4	-38.1	-1.55	-21.86	Upgrade
Interest & Investment Income	84.2	82	100.9	58.1	18.9	18.2	Upgrade
Currency Exchange Gain (Loss)	4.6	3.9	7.3	0.2	-2.75	-1.77	Upgrade
Other Non Operating Income (Expenses)	1.3	1.6	4.9	-5.2	0.68	-1.81	Upgrade
EBT Excluding Unusual Items	315.7	307.6	401.5	497.6	580.01	414.08	Upgrade
Merger & Restructuring Charges	-26.1	-	-	-	-64.4	-	Upgrade
Gain (Loss) on Sale of Investments	-3,040	-2,650	-1,252	-5,203	4,933	4,492	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	1.4	-	11.7	Upgrade
Pretax Income	-2,750	-2,343	-850.1	-4,704	5,449	4,918	Upgrade
Income Tax Expense	-586.1	-498.3	-212.8	-1,077	1,195	1,104	Upgrade
Net Income	-2,164	-1,844	-637.3	-3,628	4,254	3,814	Upgrade
Net Income to Common	-2,164	-1,844	-637.3	-3,628	4,254	3,814	Upgrade
Net Income Growth	-	-	-	-	11.54%	116.88%	Upgrade
Shares Outstanding (Basic)	28	28	29	30	30	30	Upgrade
Shares Outstanding (Diluted)	28	28	29	30	30	30	Upgrade
Shares Change (YoY)	-3.00%	-3.41%	-1.93%	-1.40%	0.16%	-0.08%	Upgrade
EPS (Basic)	-77.10	-65.36	-21.82	-121.79	142.61	128.13	Upgrade
EPS (Diluted)	-77.10	-65.36	-21.82	-121.79	140.83	126.47	Upgrade
EPS Growth	-	-	-	-	11.35%	117.04%	Upgrade
Free Cash Flow	355.5	289.6	218.2	81.6	535.75	476.44	Upgrade
Free Cash Flow Per Share	12.66	10.26	7.47	2.74	17.74	15.80	Upgrade
Gross Margin	53.64%	53.73%	53.42%	55.93%	56.91%	56.48%	Upgrade
Operating Margin	10.79%	10.48%	12.65%	17.22%	19.32%	16.55%	Upgrade
Profit Margin	-85.16%	-71.86%	-23.86%	-129.45%	145.57%	149.84%	Upgrade
Free Cash Flow Margin	13.99%	11.28%	8.17%	2.91%	18.33%	18.72%	Upgrade
EBITDA	426.8	420.6	483.7	619.9	702.34	559.93	Upgrade
EBITDA Margin	16.80%	16.39%	18.11%	22.12%	24.03%	22.00%	Upgrade
D&A For EBITDA	152.6	151.6	145.9	137.3	137.6	138.6	Upgrade
EBIT	274.2	269	337.8	482.6	564.74	421.33	Upgrade
EBIT Margin	10.79%	10.48%	12.65%	17.22%	19.32%	16.55%	Upgrade
Effective Tax Rate	-	-	-	-	21.93%	22.44%	Upgrade

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q